HUENENBERG, Switzerland—Alcon, Inc. (NYSE: ACL) has entered into a patent cross-licensing agreement with Advanced Medical Optics, Inc. (NYSE: EYE) relating to lubricious coatings for intraocular lens (IOL) insertion devices and a specified one-piece IOL design, according to an announcement from Alcon.

The agreement provides AMO with paid-up, non-exclusive, worldwide licenses under a family of Alcon patents. The licenses are restricted to single piece IOLs having essentially the same design as AMO's recently launched Tecnis Model ZCB00 IOL. The licenses allow AMO to operate with respect to the subject Alcon patents, relative to the Model ZCB00 IOL lens and any future IOL models having the same design platform. AMO will pay Alcon a lump sum of $10 million for these licenses.

In addition, Alcon will receive paid-up, non-exclusive, worldwide licenses under two families of patents owned by AMO. The licenses allow Alcon to operate with respect to the subject AMO patents, relative to the coating systems currently utilized in its Monarch and Acrysert brand IOL insertion devices, as well as any future coating systems of a similar type that Alcon may develop. Alcon will pay AMO a lump sum of $31 million for
these licenses.

All other terms of the agreement are confidential.